Last $75.06 USD
Change Today -1.08 / -1.42%
Volume 1.0M
DVA On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (DVA) Snapshot

Open
$75.69
Previous Close
$76.14
Day High
$76.04
Day Low
$74.96
52 Week High
10/31/14 - $78.52
52 Week Low
02/4/14 - $62.52
Market Cap
16.1B
Average Volume 10 Days
844.4K
EPS TTM
$3.72
Shares Outstanding
214.9M
EX-Date
--
P/E TM
20.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for DAVITA HEALTHCARE PARTNERS I (DVA)

davita healthcare partners i (DVA) Related Businessweek News

View More BusinessWeek News

davita healthcare partners i (DVA) Details

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of March 31, 2014, it operated 2,173 outpatient dialysis centers, including 2,098 centers located in the United States; and 75 centers located in 10 countries outside the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.

57,400 Employees
Last Reported Date: 02/21/14
Founded in 1994

davita healthcare partners i (DVA) Top Compensated Officers

Co-Chairman, Chief Executive Officer and Chie...
Total Annual Compensation: $1.1M
Chief Financial Officer
Total Annual Compensation: $213.6K
Chief Executive Officer of Kidney Care Divisi...
Total Annual Compensation: $765.4K
Chief Accounting Officer
Total Annual Compensation: $650.0K
Chief Legal Officer
Total Annual Compensation: $650.0K
Compensation as of Fiscal Year 2013.

davita healthcare partners i (DVA) Key Developments

Centura Health and DaVita HealthCare Partners Introduce FullWell

Centura Health and DaVita HealthCare Partners unveiled FullWell, the brand name of the two partners' recently announced joint venture, a company that aims to bring greater value to health care and lower costs for consumers in Colorado and Kansas. FullWell, when launched, will combine the expertise of the region's leading health care system with a nationally recognized leader in physician-centric coordinated care to transform the way health care is delivered. Specifically, FullWell will equip providers of Colorado Health Neighborhoods (CHN), the Centura Health physician-led network, with immediate access to data analytics. This data delivers critical information to support early identification of patients at high risk for chronic health conditions and real-time feedback on the efficacy of treatments consumers may be receiving. FullWell will employ tools to help engage, inform and empower consumers to actively manage and maintain their health through the trusting relationship with their provider. Additionally, FullWell brings access to improved information systems, team-based care coordination and financial incentives for better health outcomes to providers.

Davita Healthcare Partners Inc. to Settle Shareholder Lawsuits Stemming from Federal Kickback Settlement

DaVita Healthcare Partners Inc., after agreeing already to pay the federal government $389 million to settle allegations that it violated an anti-kickback law announced that it will pay out roughly $7.3 million more to settle lawsuits from shareholders regarding that episode. The company filed forms with the U.S. Securities Exchange Commission indicating that it plans to settle two derivative claims lawsuits brought by shareholders claiming that company officials breached their fiduciary duties when they entered into joint ventures with doctors who would refer patients to DaVita dialysis clinics. Under the proposed settlement, the lead plaintiff, Haverhill Retirement System, would receive an incentive fee for $10,000 and attorneys for the plaintiffs would receive $7.3 million.

Kentucky State Announces $22 Million Settlement with Davita Healthcare Partners

Attorney General Jack Conway announced that Kentucky has joined with four other states and the federal government in reaching a $22 million settlement with DaVita Healthcare Partners. The agreement settles allegations that DaVita paid illegal kickbacks to induce the referral of patients to its dialysis clinics, thereby causing false claims to be submitted to the state's Medicaid program.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $75.06 USD -1.08

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apollo Medical Holdings Inc $0.45 USD 0.00
Fresenius Medical Care AG & Co KGaA €65.53 EUR -0.48
Fresenius SE & Co KGaA €50.71 EUR -0.275
IPC Healthcare Inc $40.36 USD -0.62
Team Health Holdings Inc $51.70 USD -0.29
View Industry Companies
 

Industry Analysis

DVA

Industry Average

Valuation DVA Industry Range
Price/Earnings 22.3x
Price/Sales 1.3x
Price/Book 3.2x
Price/Cash Flow 12.4x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit www.davita.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.